These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

821 related articles for article (PubMed ID: 27050252)

  • 21. The Effects of Soy Isoflavones on Metabolic Status of Patients With Polycystic Ovary Syndrome.
    Jamilian M; Asemi Z
    J Clin Endocrinol Metab; 2016 Sep; 101(9):3386-94. PubMed ID: 27490918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vitamin D Decreases Serum VEGF Correlating with Clinical Improvement in Vitamin D-Deficient Women with PCOS: A Randomized Placebo-Controlled Trial.
    Irani M; Seifer DB; Grazi RV; Irani S; Rosenwaks Z; Tal R
    Nutrients; 2017 Mar; 9(4):. PubMed ID: 28350328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vitamin D and probiotic co-supplementation affects mental health, hormonal, inflammatory and oxidative stress parameters in women with polycystic ovary syndrome.
    Ostadmohammadi V; Jamilian M; Bahmani F; Asemi Z
    J Ovarian Res; 2019 Jan; 12(1):5. PubMed ID: 30665436
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of high-dose vitamin E supplementation on biomarkers of kidney injury, inflammation, and oxidative stress in patients with diabetic nephropathy: A randomized, double-blind, placebo-controlled trial.
    Khatami PG; Soleimani A; Sharifi N; Aghadavod E; Asemi Z
    J Clin Lipidol; 2016; 10(4):922-929. PubMed ID: 27578124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selenium Supplementation and the Effects on Reproductive Outcomes, Biomarkers of Inflammation, and Oxidative Stress in Women with Polycystic Ovary Syndrome.
    Razavi M; Jamilian M; Kashan ZF; Heidar Z; Mohseni M; Ghandi Y; Bagherian T; Asemi Z
    Horm Metab Res; 2016 Mar; 48(3):185-90. PubMed ID: 26267328
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Effects of Omega-3 Fatty Acids and Vitamin E Co-Supplementation on Indices of Insulin Resistance and Hormonal Parameters in Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Ebrahimi FA; Samimi M; Foroozanfard F; Jamilian M; Akbari H; Rahmani E; Ahmadi S; Taghizadeh M; Memarzadeh MR; Asemi Z
    Exp Clin Endocrinol Diabetes; 2017 Jun; 125(6):353-359. PubMed ID: 28407657
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of folate supplementation on inflammatory factors and biomarkers of oxidative stress in overweight and obese women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled clinical trial.
    Bahmani F; Karamali M; Shakeri H; Asemi Z
    Clin Endocrinol (Oxf); 2014 Oct; 81(4):582-7. PubMed ID: 24628390
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Effects of Magnesium and Vitamin E Co-Supplementation on Hormonal Status and Biomarkers of Inflammation and Oxidative Stress in Women with Polycystic Ovary Syndrome.
    Shokrpour M; Asemi Z
    Biol Trace Elem Res; 2019 Sep; 191(1):54-60. PubMed ID: 30565017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of vitamin D supplementation in combination with low-calorie diet on anthropometric indices and androgen hormones in women with polycystic ovary syndrome: a double-blind, randomized, placebo-controlled trial.
    Jafari-Sfidvajani S; Ahangari R; Hozoori M; Mozaffari-Khosravi H; Fallahzadeh H; Nadjarzadeh A
    J Endocrinol Invest; 2018 May; 41(5):597-607. PubMed ID: 29110281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Effects of Vitamin D Supplementation on Biomarkers of Inflammation and Oxidative Stress Among Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Akbari M; Ostadmohammadi V; Lankarani KB; Tabrizi R; Kolahdooz F; Heydari ST; Kavari SH; Mirhosseini N; Mafi A; Dastorani M; Asemi Z
    Horm Metab Res; 2018 Apr; 50(4):271-279. PubMed ID: 29475212
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Trial on The Effects of Magnesium-Zinc-Calcium-Vitamin D Co-Supplementation on Glycemic Control and Markers of Cardio-Metabolic Risk in Women with Polycystic Ovary Syndrome.
    Jamilian M; Maktabi M; Asemi Z
    Arch Iran Med; 2017 Oct; 20(10):640-645. PubMed ID: 29137465
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Influences of Chromium Supplementation on Glycemic Control, Markers of Cardio-Metabolic Risk, and Oxidative Stress in Infertile Polycystic ovary Syndrome Women Candidate for In vitro Fertilization: a Randomized, Double-Blind, Placebo-Controlled Trial.
    Jamilian M; Zadeh Modarres S; Amiri Siavashani M; Karimi M; Mafi A; Ostadmohammadi V; Asemi Z
    Biol Trace Elem Res; 2018 Sep; 185(1):48-55. PubMed ID: 29307112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vitamin D supplementation has no effect on insulin resistance assessment in women with polycystic ovary syndrome and vitamin D deficiency.
    Ardabili HR; Gargari BP; Farzadi L
    Nutr Res; 2012 Mar; 32(3):195-201. PubMed ID: 22464806
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Omega-3 and vitamin E co-supplementation can improve antioxidant markers in obese/overweight women with polycystic ovary syndrome.
    Sadeghi F; Alavi-Naeini A; Mardanian F; Ghazvini MR; Mahaki B
    Int J Vitam Nutr Res; 2020 Oct; 90(5-6):477-483. PubMed ID: 30961460
    [No Abstract]   [Full Text] [Related]  

  • 35. The Effect of Magnesium and Vitamin E Co-Supplementation on Glycemic Control and Markers of Cardio-Metabolic Risk in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Jamilian M; Sabzevar NK; Asemi Z
    Horm Metab Res; 2019 Feb; 51(2):100-105. PubMed ID: 30286483
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of vitamin D, K and calcium co-supplementation on carotid intima-media thickness and metabolic status in overweight type 2 diabetic patients with CHD.
    Asemi Z; Raygan F; Bahmani F; Rezavandi Z; Talari HR; Rafiee M; Poladchang S; Darooghegi Mofrad M; Taheri S; Mohammadi AA; Esmaillzadeh A
    Br J Nutr; 2016 Jul; 116(2):286-93. PubMed ID: 27198036
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vitamin D improves levels of hormonal, oxidative stress and inflammatory parameters in polycystic ovary syndrome: a meta-analysis study.
    Zhao JF; Li BX; Zhang Q
    Ann Palliat Med; 2021 Jan; 10(1):169-183. PubMed ID: 33545754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of vitamin D supplementation on insulin resistance, visceral fat and adiponectin in vitamin D deficient women with polycystic ovary syndrome: a randomized placebo-controlled trial.
    Seyyed Abootorabi M; Ayremlou P; Behroozi-Lak T; Nourisaeidlou S
    Gynecol Endocrinol; 2018 Jun; 34(6):489-494. PubMed ID: 29271278
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Magnesium-zinc-calcium-vitamin D co-supplementation improves glycemic control and markers of cardiometabolic risk in gestational diabetes: a randomized, double-blind, placebo-controlled trial.
    Karamali M; Bahramimoghadam S; Sharifzadeh F; Asemi Z
    Appl Physiol Nutr Metab; 2018 Jun; 43(6):565-570. PubMed ID: 29316405
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of vitamin D supplementation on metabolic profiles and gene expression of insulin and lipid metabolism in infertile polycystic ovary syndrome candidates for in vitro fertilization.
    Dastorani M; Aghadavod E; Mirhosseini N; Foroozanfard F; Zadeh Modarres S; Amiri Siavashani M; Asemi Z
    Reprod Biol Endocrinol; 2018 Oct; 16(1):94. PubMed ID: 30286768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.